1 |
CCL5, COL16A1, COL3A1, COL5A1, COL5A2, collagen, Collagen Alpha1, Collagen type I, Collagen type IV, Collagen(s), CSF1R, CTSB, CTSK, Elastase, ENTPD1, ERK1/2, Fibrinogen, FLI1, GRN, IL1, Laminin, Laminin1, LDL, Mek, Mmp, MMP2, MMP7, P38 MAPK, Pdgf (complex), PDGF BB, PLA2G5, SLC1A1, Tgf beta, TGFBI, THY1 |
Connective Tissue Disorders, Genetic Disorder, Connective Tissue Development and Function |
Integrin binding |
6.7E-7 |
Protein complex binding |
8.0E-5 |
Extracellular matrix structural constituent |
4.9E-3 |
Endopeptidase activity |
1.0E-2 |
Platelet-derived growth factor binding |
1.3E-2 |
2 |
ANXA4, BCL11B, CD3, CD8, CD3G, CD8A, CLEC7A, CORO1A, HLA-B, HLADMA, HLA-DMB, HLA-DPB1, HLADQB1 (includes others), HLA-DR, HLADRA, Hla-Drb, HLA-DRB1, IFN Beta, Ifn gamma, IgG, IL-2R, IL12 (complex), IL2RG, Interferon alpha, LCK, MHC, MHC Class I (complex), Mhc class ii, MHC Class II (complex), MHC II-β, Mhc2 Alpha, NFAT (complex), NFkB (complex), TCR, TNFAIP2 |
Genetic Disorder, Skeletal and Muscular Disorders, Cell-To-Cell Signaling and Interaction |
MHC class II receptor activity |
7.5E-12 |
MHC protein binding |
1.1E-8 |
MHC class I protein binding |
5.5E-7 |
Phosphoinositide 3-kinase binding |
1.1E-2 |
Peptide binding |
2.0E-2 |